V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330002980 | 330001590 | 1.74 | 89 | Curative (C) | 2015-02-21 | 2015-02-24 | CARBOPLATIN | 02 | N | 330011918 | CARBOPLATIN |
| 330002981 | 330001591 | 1.7 | 68 | Curative (C) | 2016-03-30 | 2016-04-30 | Liposomal Doxorubicin (20mg/m2) | N | N | 330011919 | LIPOSOMAL DOXORUBICIN |
| 330002982 | 330006851 | 1.66 | 63.4 | null | 2014-02-27 | 2014-02-27 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | 330011920 | CARBOPLATIN + PACLITAXEL |
| 330002984 | 330001592 | null | 68.8 | Curative (C) | 2013-01-27 | 2013-02-04 | CARBOPLATIN + ETOPOSIDE | N | N | 330011924 | CARBOPLATIN + ETOPOSIDE |
| 330002985 | 330001593 | 1.65 | 66.9 | Adjuvant (A) | 2017-10-08 | 2017-10-27 | Cisplatin + Doxorubicin | N | N | 330011926 | CISPLATIN + DOXORUBICIN |
| 330002986 | 330001593 | 1.58 | 84.6 | Curative (C) | 2015-08-12 | 2015-08-12 | Rituximab | null | N | 330011926 | RITUXIMAB |
| 330002987 | 330001593 | null | 55.6 | null | 2016-05-30 | 2016-06-03 | Cisplatin + Doxorubicin | N | null | 330011926 | CISPLATIN + DOXORUBICIN |
| 330002988 | 330001593 | 1.68 | 68 | Palliative (P) | null | 2017-07-05 | Carboplatin + Paclitaxel (3 weekly) | N | null | 330011926 | CARBOPLATIN + PACLITAXEL |
| 330002989 | 330012142 | null | 77 | Palliative (P) | null | 2014-01-26 | Rituximab | N | N | 330011931 | RITUXIMAB |
| 330002990 | 330001594 | 1.56 | null | Palliative (P) | 2017-04-09 | 2017-04-10 | CARBOPLATIN + PACLITAXEL | N | N | 330011932 | CARBOPLATIN + PACLITAXEL |
| 330002991 | 330001595 | 1.66 | 65.6 | Palliative (P) | 2016-04-29 | 2016-05-10 | DOXORUBICIN | N | N | 330011933 | DOXORUBICIN |
| 330002992 | 330001596 | 1.81 | 79.8 | Palliative (P) | 2016-03-14 | 2016-03-23 | DOXORUBICIN | 02 | N | 330011936 | DOXORUBICIN |
| 330002993 | 330001596 | 1.81 | 84.4 | Palliative (P) | 2017-01-12 | 2017-01-12 | DOXORUBICIN | N | N | 330011936 | DOXORUBICIN |
| 330002994 | 330001596 | 1.86 | 72.3 | Palliative (P) | 2017-03-03 | 2017-03-03 | BENDAMUSTINE + RITUXIMAB | 2 | N | 330011936 | BENDAMUSTINE + RITUXIMAB |
| 330002995 | 330001596 | 1.55 | 54.4 | Palliative (P) | 2013-05-22 | 2013-06-12 | CARBOPLATIN + PACLITAXEL | N | N | 330011936 | CARBOPLATIN + PACLITAXEL |
| 330002996 | 330001596 | 1.8 | 75.8 | null | 2014-02-10 | 2014-02-10 | Rituximab | 2 | Y | 330011936 | RITUXIMAB |
| 330002997 | 330001597 | 1.63 | 73.8 | Palliative (P) | 2016-03-16 | 2016-03-01 | Carboplatin + Paclitaxel (weekly) | N | N | 330011949 | CARBOPLATIN + PACLITAXEL |
| 330002998 | 330001598 | 1.73 | 73.6 | Curative (C) | 2014-12-02 | 2014-12-07 | Rituximab | N | N | 330011950 | RITUXIMAB |
| 330002999 | 330001598 | 0 | 89 | Palliative (P) | 2013-10-24 | 2013-10-28 | Liposomal Doxorubicin (Caelyx) | 2 | N | 330011950 | LIPOSOMAL DOXORUBICIN |
| 330003000 | 330001598 | null | 88.9 | Palliative (P) | 2016-02-23 | 2016-02-23 | Cisplatin + Doxorubicin | N | N | 330011950 | CISPLATIN + DOXORUBICIN |
| 330003001 | 330011275 | 0 | 68.3 | null | 2015-12-02 | 2016-08-31 | Cisplatin + Doxorubicin | 2 | N | 330011957 | CISPLATIN + DOXORUBICIN |
| 330003002 | 330011275 | 1.66 | 91.4 | Palliative (P) | 2017-05-08 | 2017-05-16 | Liposomal Doxorubicin (20mg/m2) | 2 | N | 330011957 | LIPOSOMAL DOXORUBICIN |
| 330003003 | 330011275 | 1.65 | null | Curative (C) | 2015-11-26 | 2015-12-02 | Cisplatin + Doxorubicin | null | null | 330011957 | CISPLATIN + DOXORUBICIN |
| 330003004 | 330011275 | 1.8 | 73.3 | Disease modification (D) | 2013-09-21 | 2013-10-02 | Bendamustine+Rituximab (1st Course) | N | N | 330011957 | BENDAMUSTINE + RITUXIMAB |
| 330003005 | 330011275 | 1.67 | 107 | null | 2013-10-16 | 2013-10-17 | CARBOPLATIN | N | N | 330011957 | CARBOPLATIN |
| 330003006 | 330011275 | 1.52 | 62.4 | Palliative (P) | 2017-10-19 | 2017-10-25 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330011957 | CARBOPLATIN + PACLITAXEL |
| 330003007 | 330001599 | 1.59 | 101.8 | Curative (C) | null | 2015-08-21 | Cisplatin + Doxorubicin | N | N | 330011967 | CISPLATIN + DOXORUBICIN |
| 330003008 | 330001600 | 1.76 | 71.6 | Not known (9) | 2013-06-17 | 2013-06-19 | Rituximab | N | N | 330011969 | RITUXIMAB |
| 330003009 | 330001600 | 1.57 | 67 | Palliative (P) | 2017-01-08 | 2017-01-08 | BENDAMUSTINE + RITUXIMAB | N | N | 330011969 | BENDAMUSTINE + RITUXIMAB |
| 330003010 | 330001601 | null | 84.1 | Neo-adjuvant (N) | 2016-03-09 | 2016-03-14 | CARBOPLATIN | 02 | N | 330011975 | CARBOPLATIN |
| 330003011 | 330001602 | 1.87 | 76 | Palliative (P) | null | 2013-04-24 | Doxorubicin 75mg/m2 | 02 | null | 330011977 | DOXORUBICIN |
| 330003012 | 330001603 | 1.7 | 50.2 | Palliative (P) | 2014-05-10 | 2014-05-24 | Liposomal Doxorubicin (20mg/m2) | 02 | N | 330011980 | LIPOSOMAL DOXORUBICIN |
| 330003013 | 330001604 | 1.62 | 47.3 | Palliative (P) | 2018-03-28 | 2018-04-08 | BENDAMUSTINE + RITUXIMAB | null | N | 330011981 | BENDAMUSTINE + RITUXIMAB |
| 330003014 | 330001605 | null | 76.2 | Palliative (P) | 2014-10-26 | 2014-11-13 | BENDAMUSTINE + RITUXIMAB | N | N | 330011982 | BENDAMUSTINE + RITUXIMAB |
| 330003015 | 330001605 | 1.77 | 66 | Palliative (P) | 2015-12-14 | 2015-12-20 | Carboplatin + Paclitaxel (weekly) | 2 | N | 330011982 | CARBOPLATIN + PACLITAXEL |
| 330003016 | 330001605 | 1.78 | 76.45 | Curative (C) | 2016-06-13 | 2016-06-14 | Cisplatin + Doxorubicin | N | N | 330011982 | CISPLATIN + DOXORUBICIN |
| 330003017 | 330001605 | null | null | Palliative (P) | 2017-03-13 | 2017-03-29 | Cisplatin + Doxorubicin | N | N | 330011982 | CISPLATIN + DOXORUBICIN |
| 330003018 | 330012145 | 1.86 | 95 | Palliative (P) | null | 2018-02-24 | CARBOPLATIN + PACLITAXEL | N | N | 330011991 | CARBOPLATIN + PACLITAXEL |
| 330003019 | 330012145 | null | 73 | Palliative (P) | 2015-03-23 | 2015-03-24 | Cisplatin + Doxorubicin | N | N | 330011991 | CISPLATIN + DOXORUBICIN |
| 330003020 | 330001606 | 1.62 | 72.2 | Palliative (P) | 2017-07-02 | 2017-07-05 | Carboplatin + Paclitaxel (3 weekly) | N | N | 330011996 | CARBOPLATIN + PACLITAXEL |
| 330003021 | 330001607 | 1.74 | 64.2 | null | 2014-07-29 | 2014-08-05 | Cisplatin + Doxorubicin | 2 | null | 330011998 | CISPLATIN + DOXORUBICIN |
| 330003022 | 330001608 | 1.6 | 57.2 | Disease modification (D) | 2017-05-26 | 2017-06-02 | BENDAMUSTINE + RITUXIMAB | 02 | N | 330012001 | BENDAMUSTINE + RITUXIMAB |
| 330003023 | 330001609 | 1.65 | 56 | Not known (9) | 2016-08-10 | 2016-08-30 | Cisplatin + Doxorubicin | N | N | 330012004 | CISPLATIN + DOXORUBICIN |
| 330003024 | 330001610 | 1.74 | 81.1 | Palliative (P) | 2014-08-27 | 2014-09-01 | Liposomal Doxorubicin (Caelyx) | 2 | N | 330012006 | LIPOSOMAL DOXORUBICIN |
| 330003025 | 330001611 | null | 68 | Neo-adjuvant (N) | 2015-03-30 | 2015-04-11 | Cisplatin + Doxorubicin | 99 | N | 330012007 | CISPLATIN + DOXORUBICIN |
| 330003026 | 330001612 | 1.59 | 70 | Disease modification (D) | 2016-10-27 | 2016-11-04 | Rituximab | 02 | N | 330012008 | RITUXIMAB |
| 330003027 | 330006857 | 1.58 | null | Curative (C) | 2016-05-20 | 2016-05-20 | Carboplatin AUC 2 - 5 | 2 | null | 330012010 | CARBOPLATIN |
| 330003028 | 330001613 | 1.72 | 73 | Not known (9) | 2016-09-03 | 2016-09-03 | Liposomal Doxorubicin (20mg/m2) | N | N | 330012016 | LIPOSOMAL DOXORUBICIN |
| 330003029 | 330001613 | 1.54 | 61 | Palliative (P) | 2015-05-02 | 2015-05-02 | Liposomal Doxorubicin (Caelyx) | N | N | 330012016 | LIPOSOMAL DOXORUBICIN |
| 330003030 | 330001613 | 1.9 | 79.3 | Curative (C) | 2014-08-11 | 2014-08-11 | CARBOPLATIN | N | N | 330012016 | CARBOPLATIN |